Unique life science investment opportunity in Southern Sweden and Medicon Valley

AstraZeneca's decision to vacate its respiratory and inflammation R&D facilities presents a golden opportunity for companies around the world to take advantage of a unique location with outstanding resources.

Find the best match for your competence needs
Are you looking for skilled personnel and/or to invest in an innovative environment?  Invest in Skåne has mapped and profiled AstraZeneca's competence base to facilitate new engagements and support companies interested in investing in Skåne.

Invest in Skåne can provide you with the following information:

• An overview of the Life Science business in Lund and Skåne
• The current recruitment opportunity from the available competence pool
• How Invest in Skåne can support you in exploring opportunities

Click here to download the presentation (pdf)

Competence base (% split across areas of expertise)

Source: Survey performed March 2011 with 343 respondents from AZ R&D site in Lund.